Requiring Transparency and Value-Based Care in the Pharmaceutical Industry: John O’Brien, National Pharmaceutical Council
In this episode, National Pharmaceutical Council (NPC) President and CEO John O’Brien, PharmD, MPH, joins Real Chemistry’s Founder and Chairman, Jim Weiss, to discuss the pharmaceutical industry, the value assessment of medicines, the role of government in drug pricing and the importance of research in healthcare policy. Tune in to get the latest insights on the lack of clarity in government guidelines, the hostile environment for the pharmaceutical industry, the shift in benefits and the rise in patient costs, and the need for more transparency and value-based care.
